Xultophy Interactions
There are 416 drugs known to interact with Xultophy (insulin degludec/liraglutide), along with 8 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 29 are major, 362 are moderate, and 25 are minor.
- View all 416 medications that may interact with Xultophy
- View Xultophy alcohol/food interactions (2)
- View Xultophy disease interactions (8)
Most frequently checked interactions
View interaction reports for Xultophy (insulin degludec / liraglutide) and the medicines listed below.
- albuterol
- allopurinol
- amlodipine
- aspirin
- atenolol
- atorvastatin
- bisoprolol
- Crestor (rosuvastatin)
- fenofibrate
- furosemide
- gabapentin
- glimepiride
- Jardiance (empagliflozin)
- Levemir (insulin detemir)
- levothyroxine
- lisinopril
- losartan
- Lyrica (pregabalin)
- metformin
- Metoprolol Tartrate (metoprolol)
- Novolog (insulin aspart)
- omeprazole
- Ozempic (semaglutide)
- pantoprazole
- potassium chloride
- Tresiba (insulin degludec)
- Trulicity (dulaglutide)
- Victoza (liraglutide)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Xultophy alcohol/food interactions
There are 2 alcohol/food interactions with Xultophy (insulin degludec / liraglutide).
Xultophy disease interactions
There are 8 disease interactions with Xultophy (insulin degludec / liraglutide) which include:
- pancreatitis
- thyroid carcinoma
- depression
- renal dysfunction
- renal/liver disease
- hypokalemia
- hypoglycemia
- cardiovascular disease
More about Xultophy (insulin degludec / liraglutide)
- Xultophy consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antidiabetic combinations
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.